All | No delirium | Delirium | ||
---|---|---|---|---|
(n = 562) | (n = 473) 84% | (n = 89) 16% | P | |
Admission and preadmission patient characteristics: | ||||
Age in years, median (IQR) | 66 (54-74) | 64 (53-73) | 73 (61-81) | <0.001a |
Age group, n (%) | <0.001b | |||
65 years | 284 (51) | 223 (47) | 61 (69) | |
<65 years | 278 (49) | 250 (53) | 28 (32) | |
Gender, n (%) | 0.346b | |||
Male | 354 (63) | 294 (62) | 60 (67) | |
Female | 208 (37) | 179 (38) | 29 (33) | |
ASA physical status, n (%) | <0.001b | |||
I/II | 189 (34) | 175 (37) | 14 (16) | |
III/IV | 373 (66) | 298 (63) | 75 (84) | |
Body mass index in kg/m2, median (IQR) | 25 (23-28) | 25 (23-28) | 26 (23-29) | 0.231a |
Duration of anesthesia (min.), median (IQR) | 240 (180-330) | 240 (180-330) | 240 (180-330) | 0.343a |
Type of anesthesia, n (%) | 0.903a | |||
General/combined general locoregional | 476 (85) | 401 (85) | 75 (84) | |
Locoregional | 86 (15) | 72 (15) | 14 (16) | |
Temperature at SICU admission, median (IQR) | 35.0 (33.9-35.8) | 35.0 (33.9-35.8) | 35.0 (34.0-35.6) | 0.905a |
Troponin I at SICU admission, median (IQR) | 0.01(0.01-0.02) | 0.01(0.01-0.01) | 0.01(0.01-0.02) | 0.001a |
Hypertension, n (%) | 341 (61) | 275 (58) | 66 (74) | 0.005b |
Hyperlipidemia, n (%) | 224 (40) | 175 (37) | 49 (55) | 0.001b |
COPD, n (%) | 132 (24) | 105 (22) | 27 (30) | 0.097b |
High-risk surgery, n (%) | 294 (52) | 247 (52) | 47 (53) | 0.919b |
Ischemic heart disease, n (%) | 104 (19) | 75 (16) | 29 (33) | <0.001b |
Congestive heart disease, n (%) | 175 (31) | 132 (28) | 43 (48) | <0.001b |
Cerebrovascular disease, n (%) | 94 (17) | 71 (15) | 23 (26) | 0.012b |
Renal insufficiency, n (%) | 40 (7) | 33 (7) | 7 (8) | 0.765b |
Insulin therapy for diabetes, n (%) | 40 (7) | 30 (6) | 10 (11) | 0.100b |
Total RCRI, n (%) | 0.001b | |||
≤2 | 487 (87) | 420 (89) | 67 (75) | |
>2 | 75 (13) | 53 (11) | 22 (25) | |
Crystalloids, median (IQR) | 2511 (2000-4206) | 2500 (2000-4148) | 3000 (2000-4950) | 0.324a |
Colloids, n (%) | 176 (31) | 143 (30) | 33 (37) | 0.201b |
Erythrocytes, n (%) | 172 (31) | 138 (29) | 34 (38) | 0.090b |
Fresh frozen plasma, n (%) | 14 (3) | 8 (2) | 6 (7) | 0.005b |
Platelets, n (%) | 3 (1) | 2 (0.4) | 1 (1) | 0.405b |
Outcomes: | ||||
APACHE II score, median (IQR) | 8 (5-11) | 8 (5-10) | 9 (7-12) | <0.001a |
SICU length of stay (hours), median (IQR) | 19 (16-30) | 19 (15-23) | 23 (18-71) | <0.001a |
Hospital length of stay (days), median (IQR) | 12 (5-24) | 11 (5-23) | 18 (9-35) | <0.001a |
Mortality in SICU, n (%) | 3 (1) | 1 (0.2) | 2 (2) | 0.067b |
Mortality in hospital, n (%) | 30 (5) | 15 (3) | 15 (17) | <0.001b |
Mortality at six-month follow-up, n (%) | 74 (13) | 46 (10) | 28 (32) | <0.001b |